Libnny Belmar

Libnny Belmar

Auto-generated profile, based on publicly available information

Libnny Belmar

Laboratory of Bacterial Pathogenicity, Department of Microbiology, Faculty of Biological Sciences, Universidad de Concepcion, Concepcion 4070386, Chile

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
Kimberly Sánchez-AlonzoKimberly Sánchez-Alonzo
Kimberly Sánchez-Alonzo
LBLibnny Belmar
Libnny Belmar
Cristian Andres Parra SepúlvedaCristian Andres Parra Sepúlveda
Cristian Andres Parra Sepúlveda
HBHumberto Bernasconi
Humberto Bernasconi
VCVíctor L. Campos
Víctor L. Campos
ACApolinaria Garcia Cancino
Apolinaria Garcia Cancino
First-line treatment for Helicobacter pylori includes amoxicillin and clarithromycin or metronidazole plus a proton pump inhibitor. Treatment failure is associated with antibiotic resistance and possibly also with internalization of H. pylori into eukaryotic cells, such as yeasts. Factors triggering the entry of H. pylori into yeast are poorly understood. Therefore, the aim of this study was to evaluate whether clarithromycin or amoxicillin trigger the entry of H. pylori into C. albicans cells. Methods: H. pylori J99 and C. albicans ATCC 10231 were co-cultured in the presence of subinhibitory concentrations of amoxicillin and clarithromycin as stressors. Bacterial-bearing yeasts were observed by fresh examination. The viability of bacteria within yeasts was evaluated, confirming the entry of bacteria into Candida, amplifying, by PCR, the H. pylori16S rRNA gene in total yeast DNA. Results: Amoxicillin significantly increased the entry of H. pylori into C. albicans compared to the control. Conclusion: the internalization of H. pylori into C. albicans in the presence of antibiotics is dependent on the type of antibiotic used, and it suggests that a therapy including amoxicillin may stimulate the entry of the bacterium into Candida, thus negatively affecting the success of the treatment.